Re: March Madness
|
3
|
Resverlogix Corp.
|
Mar 14, 2017 04:09PM
|
Re: March Madness?
|
3
|
Resverlogix Corp.
|
Mar 12, 2018 12:16PM
|
Re: March Presentation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 24, 2021 05:30PM
|
Re: March Presentation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 24, 2021 05:37PM
|
Re: March Presentation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 07:34AM
|
Re: Marching on to March events
|
5
|
Zenith Epigenetics
|
Feb 15, 2018 04:30PM
|
Re: Marching on to March events
|
5
|
Zenith Epigenetics
|
Feb 15, 2018 04:38PM
|
Re: Marching on to March events
|
4
|
Zenith Epigenetics
|
Mar 12, 2018 12:15PM
|
Re: Marching on to March events
|
1
|
Resverlogix Corp.
|
Feb 14, 2018 08:48PM
|
Re: Mark Day interview with Stock News Now
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 27, 2019 06:49PM
|
Re: Mark Day Panelist at RESI 2017 Early Stage Therapeutics Panel
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 27, 2017 04:01PM
|
Re: Market Cap Context
|
8
|
Resverlogix Corp.
|
Jul 05, 2019 10:54AM
|
Re: Market reaction to SGLT2i and Jardiance?
|
9
|
Resverlogix Corp.
|
Nov 19, 2019 03:10PM
|
Re: Market's estimate of likelihood of success
|
7
|
Resverlogix Corp.
|
Jul 11, 2019 07:19AM
|
Re: Maybe CKD will end up being the big driver for Apabetalone....
|
2
|
Resverlogix Corp.
|
May 21, 2017 08:53PM
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 11:33AM
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 11:45AM
|
Re: mCRPC and BET inhibitors
|
5
|
Zenith Epigenetics
|
Jan 26, 2016 04:17PM
|
Re: MD&A
|
1
|
Resverlogix Corp.
|
Mar 15, 2019 09:01PM
|
Re: MD&A out
|
3
|
Resverlogix Corp.
|
Dec 14, 2018 02:26PM
|